BioCytex
BioCytex is a French specialty biotechnology subsidiary of Diagnostica Stago that develops flow cytometry kits, monoclonal antibodies, and custom diagnostic services for hemostasis, microvesicle analysis, and pharmaceutical drug development clients worldwide.
- Company typePrivate
- Founded1992
- HeadquartersMarseille, France
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioCytex does
BioCytex S.A.R.L is a French specialty biotechnology company headquartered in Marseille, France, operating as a wholly-owned subsidiary of Diagnostica Stago S.A.S, a global hemostasis diagnostics conglomerate. The company specializes in flow cytometry-based diagnostic products, monoclonal antibody production, and custom development services for the pharmaceutical and clinical diagnostics industries, with particular focus on hemostasis, thrombosis, and microvesicle analysis. BioCytex was founded in 1992 and operates with 11-50 employees, functioning as a focused R&D and specialty product unit within the larger Stago Group portfolio.
The company's product portfolio centers on ready-to-use flow cytometry kits for antigen quantification in small sample volumes with heterogeneous cell populations, calibration tools (Megamix beads, MP-Count Beads) for standardized microvesicle analysis, and the CY-QUANT MV-TF Activity chromogenic assay for measuring tissue factor activity on microvesicles with a detection limit of 3+/-1 fM, compliant with ISTH 2019 international recommendations. BioCytex also offers custom development services including monoclonal antibody production (with over 10 years of experience and 2-3 month delivery cycles), hybridoma development, antibody engineering, immunoglobulin fragmentation and conjugation, and immunomonitoring and biosimilar antibody validation services for international pharmaceutical companies engaged in pre-clinical and clinical drug development.
The business model combines one-time sales of diagnostic kits and reagents with professional services revenue from custom development engagements, both delivered via a quote-based B2B enterprise model. Distribution leverages the Stago Group's global network spanning 15+ countries. BioCytex maintains scientific partnerships with ISTH, GEHT, and AFC, and in December 2025 launched the NVDIAG LabCom joint laboratory with LISM (CNRS/Aix-Marseille Université), ANR, and Région Sud to develop nano-antibody diagnostics for multiple myeloma and acute leukemias—signaling expansion into hematological oncology. The company occupies a defensible niche as a specialty flow cytometry and microvesicle analysis brand within Stago Group's hemostasis-focused portfolio.
BioCytex firmographics
Firmographics- Name
- BioCytex
- Legal name
- BIOCYTEX S.A.R.L
- Website
- https://biocytex.fr
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioCytex is a French specialty biotechnology subsidiary of Diagnostica Stago that develops flow cytometry kits, monoclonal antibodies, and custom diagnostic services for hemostasis, microvesicle analysis, and pharmaceutical drug development clients worldwide.
- Ownership category
- akta.pro rank
BioCytex industry classification
Industry- Product category
- Hemostasis Diagnostics Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Flow Cytometry & Cellular Analysis Diagnostics (HLAHAAAF)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where BioCytex is headquartered
LocationHeadquarters
- HQ city
- Marseille
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
BioCytex business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Diagnostic products and kits: Sale of ready-to-use flow cytometry kits and microvesicle analysis products including CY-QUANT MV-TF Activity, MP-Count Beads, and Megamix calibration beads
- Custom development services: Customized services for international pharmaceutical companies including immunomonitoring development and biosimilar antibody validation for pre-clinical and clinical drug development
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
BioCytex product offering
Product offeringCore offering
BioCytex develops and sells ready-to-use flow cytometry kits and chromogenic assays for antigen quantification, microvesicle analysis, and tissue factor (TF) activity measurement, alongside custom development services including in vitro monoclonal antibody production and immunomonitoring/biosimilar antibody validation for pharmaceutical clients. Its portfolio includes the CY-QUANT MV-TF Activity test, Megamix and MP-Count calibration beads, and proprietary kits for hemostasis and cell-based diagnostics.
Product overview
BioCytex offers a portfolio of diagnostic products and services for hemostasis and microvesicle analysis. Core products include the CY-QUANT MV-TF Activity chromogenic test for tissue factor activity measurement, flow cytometry kits, and calibration tools (Megamix, MP-Count Beads). The company also provides custom development services including monoclonal antibody production and immunomonitoring validation for pharmaceutical clients. Products are part of the Stago Group diagnostic ecosystem.
Differentiator
Problem solved
Functional benefit
Brands
- CY-QUANT MV-TF Activity: A chromogenic test measuring tissue factor (TF) activity in microvesicles (MV), compliant with international ISTH recommendations
Products and services
- CY-QUANT MV-TF Activity A chromogenic test that measures tissue factor (TF) activity on microvesicles (MV) with high sensitivity and specificity, compliant with international ISTH recommendations, intended for clinical diagnostics and research laboratories working in hemostasis.
- Flow Cytometry Kits A range of ready-to-use flow cytometry kits for antigen quantification in small sample volumes containing few cells and heterogeneous populations, enabling analysis of cell size, content, and fluorescence intensity.
- CRP-A Catalog product listed in the BioCytex product catalog for diagnostic or research use.
- Megamix Calibration Beads Calibration beads used as a sizing tool for flow cytometry analysis of microvesicles, optimized for each type of cytometer to enable standardized microvesicle analysis.
- MP-Count Beads Bead suspension designed for absolute counting of microvesicles in flow cytometry applications.
- STA Procoag PPL Functional test for measuring procoagulant phospholipid activity of microvesicles.
- Monoclonal Antibody Production Services In vitro production of mouse monoclonal antibodies in 2-3 months with over 10 years of experience; services include hybridoma development, antibody engineering, and immunoglobulin fragmentation and conjugation.
- Custom Development Services Customized immunomonitoring development and biosimilar antibody validation services for international pharmaceutical companies engaged in pre-clinical and clinical drug development and biomarker research.
Quantifiable outcome
- CY-QUANT MV-TF Activity achieves very high sensitivity with a limit of detection of 3+/-1 fM
Companies that use BioCytex
Customer profileSegments2 records
Ideal customer profiles2 records
BioCytex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioCytex partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- LISM (Laboratoire d'Ingénierie des Système Macromoléculaires - CNRS/Aix-Marseille Université)coreStrategic alliance forming NVDIAG LabCom (Laboratoire Commun) focused on developing innovative nano-antibodies for improved diagnostic tests for multiple myeloma and acute leukemias. The partnership leverages synergy between BioCytex's diagnostic expertise and LISM's macromolecular engineering research capabilities.
- ANR (Agence nationale de la recherche)coreFunding agency partner in the NVDIAG LabCom initiative, supporting the joint research program for developing next-generation diagnostic tools using innovative biological mechanisms.
- Région Sud - Provence-Alpes-Côte d'AzurcoreRegional government partner co-funding the NVDIAG LabCom laboratory together with ANR, supporting regional innovation in medical diagnostics.
- Diagnostica Stago S.A.S (Parent Company)coreBioCytex is a subsidiary (Société à Responsabilité Limitée) of Diagnostica Stago S.A.S, headquartered in Asnières-sur-Seine, France. Stago is a major player in hemostasis diagnostics with global presence.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
BioCytex competitors and assessment
Company assessmentEmerging players
- NanoFCM: Specialized nano-flow cytometry platform focused on nanoparticle and microvesicle analysis. Closest emerging competitor to BioCytex's CY-QUANT MV-TF Activity and Megamix/MP-Count Beads microvesicle workflow, targeting the same research and clinical lab segment.
Direct peers
- Beckman Coulter: Major flow cytometry instruments and reagent provider with a comparable antibody/reagent portfolio. BioCytex has explicitly validated interoperability of its anti-Kappa/Lambda assays with Beckman Coulter platforms, making them direct competitors in flow cytometry reagents for clinical diagnostics.
- Bio-Rad Laboratories: Global life science tools company with significant flow cytometry reagents, antibody kits, and clinical diagnostics offerings. Directly competes with BioCytex in ready-to-use flow cytometry kits and immunology assay reagents for research and clinical labs.
- Miltenyi Biotec: Flow cytometry, cell analysis, and antibody reagent specialist with strong pharma services franchise. Comparable to BioCytex in monoclonal antibody offerings, flow cytometry kits, and custom services for clinical research.
- BD Biosciences: Leading flow cytometry instruments, antibodies, and reagent kits provider serving pharma, biotech, and clinical research customers. Comparable to BioCytex in offering flow cytometry-based assays and antibody-based diagnostic/research tools.
- Cell Signaling Technology: Specialized antibody and assay kit developer for research and clinical diagnostics. Comparable to BioCytex in producing high-quality monoclonal antibodies and assay reagents targeting specific biomarkers for the research and pharma services market.
- Abcam: Global antibody reagent supplier serving research and diagnostic markets with a deep catalog of monoclonal and polyclonal antibodies. Comparable to BioCytex's custom antibody production and reagent development business for research and clinical applications.
Broad incumbents
- Sysmex: Global in vitro diagnostics leader with a strong hemostasis and coagulation testing franchise that overlaps BioCytex's hemostasis/thrombosis focus area. Much broader portfolio but directly competes in clinical hemostasis diagnostics where BioCytex's microvesicle and tissue factor assays are positioned.
- Diagnostica Stago: BioCytex's parent company and global leader in hemostasis diagnostics. Comparable in hemostasis product portfolio, customer base (clinical labs and hospitals), and channel strategy; BioCytex operates as a specialized brand within the Stago ecosystem.
- Thermo Fisher Scientific: Diversified life sciences tools giant offering flow cytometry (via Life Technologies), antibodies, reagents, and pharma services. Overlaps with BioCytex's flow cytometry kits, antibody production, and custom services for pharma R&D at much greater scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
BioCytex social profiles
Digital presenceBioCytex financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCytex leadership team
Management profileNumber of profiles
Profiles1 record
BioCytex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCytex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCytex
What does BioCytex do?
BioCytex develops and sells ready-to-use flow cytometry kits and chromogenic assays for antigen quantification, microvesicle analysis, and tissue factor (TF) activity measurement, alongside custom development services including in vitro monoclonal antibody production and immunomonitoring/biosimilar antibody validation for pharmaceutical clients. Its portfolio includes the CY-QUANT MV-TF Activity test, Megamix and MP-Count calibration beads, and proprietary kits for hemostasis and cell-based diagnostics.
Is BioCytex a public or private company?
BioCytex is a private company. It is classified as corporate owned and is currently operating.
When was BioCytex founded?
BioCytex was founded in 1992. It employs 11 to 50 people.
Where is BioCytex based?
BioCytex is headquartered in Marseille, France, in the Europe region.
How does BioCytex make money?
Two revenue lines are on record. Diagnostic products and kits are the primary driver. The others are custom development services.
Who are BioCytex's main competitors?
NanoFCM is listed as an emerging player. Direct peers are Beckman Coulter, Bio-Rad Laboratories, Miltenyi Biotec, BD Biosciences, Cell Signaling Technology and Abcam. Broad incumbents are Sysmex, Diagnostica Stago and Thermo Fisher Scientific.
Does BioCytex have an API?
No public API is recorded for BioCytex.
What industry is BioCytex in?
BioCytex's product category is Hemostasis Diagnostics Reagents. Its primary akta.pro industry code is HLAHAAAF, Flow Cytometry & Cellular Analysis Diagnostics, with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.